Resources for You
Gadavist (Gadobutrol) Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- Gadavist is contraindicated in patients with history of severe hypersensitivity reactions to Gadavist.
WARNINGS AND PRECAUTIONS
Acute Kidney Injury
- In patients with chronic renal impairment, acute kidney injury sometimes requiring dialysis has been observed with the use of some GBCAs. Do not exceed the recommended dose; the risk of acute kidney injury may increase with higher than recommended doses.